cyclosporine has been researched along with Hemolysis in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (35.00) | 18.2507 |
| 2000's | 7 (35.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babushok, DV; Duke, JL; Huang, Y; Monos, DS; Olson, TS; Oved, JH; Stanley, N; Teachey, DT | 1 |
| Acquazzino, MA; Coulter, DW; Fischer, RT; Langnas, A | 1 |
| Asano, J; Shinzato, I; Takafuta, T; Tanaka, Y; Ueda, R | 1 |
| Almeida, AM; Muus, P; Schrezenmeier, H; Urbano-Ispizua, Á; Ware, RE; Wilson, A | 1 |
| Banov, L; Calvillo, M; Caprino, D; Dufour, C; Fioredda, F; Gallisai, D; Marinelli, D; Micalizzi, C; Molinari, AC; Schmidt, M; Svahn, J | 1 |
| Gurny, R; Möller, M; Mondon, K; Zeisser-Labouèbe, M | 1 |
| Abidogun, K; Crosfill, F; Jip, J; Mechery, J | 1 |
| Kwak, CS; Mun, KC; Suh, SI | 1 |
| Barra, D; Borro, M; Mangoni, ML; Miele, R; Simmaco, M | 1 |
| Chang, EJ; Kim, HC; Mun, KC | 1 |
| Havlicek, V; Kobliha, V; Kruppa, G; Lemr, K; Novak, P; Sevcik, K; Takats, Z | 1 |
| Brugger, S; Greinix, HT; Höcker, P; Kalhs, P; Keil, F; Knöbl, P; Kyrle, PA; Linkesch, W; Schneider, B; Schwarzinger, I | 1 |
| Hirose, M; Kuroda, Y | 1 |
| de Wolf, JT; Halie, MR; Smit, JW; van Imhoff, GW; van Kamp, H; Vellenga, E | 1 |
| Escobar, FS; Kupin, WL; Lee, MW; Mozes, MF; Nakhleh, RE; Venkat, KK; Wiener, Y | 1 |
| Alcocer, M; Briz, M; Cabrera, R; Fernández, MN; Forés, R; Lago, C; Sanjuán, I | 1 |
| Barrett, AJ; Bolan, CD; Childs, RW; Leitman, SF; Procter, JL | 1 |
| Bullorsky, E; Freixas, E; Pereyra, H; Rabinovich, O; Schropp, J; Trimarchi, H | 1 |
| McDonald, GB; Shulman, HM; Strasser, SI | 1 |
| Calhoun, L; Champlin, RE; Gajewski, JL; Ho, WG; Hunt, LA; Landaw, EM; Lyddane, NR; O'Rourke, S; Petz, LD; Schiller, GJ | 1 |
1 review(s) available for cyclosporine and Hemolysis
| Article | Year |
|---|---|
Cholestasis after hematopoietic cell transplantation.
Topics: Cholestasis; Cyclosporine; Cytomegalovirus Infections; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemolysis; Humans; Parenteral Nutrition, Total; Sepsis | 1999 |
1 trial(s) available for cyclosporine and Hemolysis
| Article | Year |
|---|---|
The effect of cyclosporine on haematological parameters in patients with paroxysmal nocturnal haemoglobinuria.
Topics: Adult; Aged; Anemia, Aplastic; Antigens, CD; Blood Cell Count; Cyclosporine; Female; Glycosylphosphatidylinositols; Hemoglobins; Hemoglobinuria, Paroxysmal; Hemolysis; Humans; Male; Neutrophils; Syndrome | 1995 |
18 other study(ies) available for cyclosporine and Hemolysis
| Article | Year |
|---|---|
Development of hemolytic paroxysmal nocturnal hemoglobinuria without graft loss following hematopoietic stem cell transplantation for acquired aplastic anemia.
Topics: Adolescent; Anemia, Aplastic; Bone Marrow Cells; Chimerism; Cyclosporine; Diabetes Mellitus, Type 1; Graft Survival; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Hemolysis; Humans; Immunosuppressive Agents; Male; Membrane Proteins; Mutation; Neutrophils; Recurrence; Thrombocytopenia; Thrombosis; Treatment Outcome | 2019 |
Refractory autoimmune hemolytic anemia after intestinal transplant responding to conversion from a calcineurin to mTOR inhibitor.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Murine-Derived; Calcineurin; Cyclophosphamide; Cyclosporine; Everolimus; Female; Hemolysis; Humans; Immunoglobulins, Intravenous; Immunosuppression Therapy; Immunosuppressive Agents; Infant; Intestines; Liver Transplantation; Male; Medical Records; Nephrotic Syndrome; Pancreas Transplantation; Penicillins; Plasmapheresis; Retrospective Studies; Rituximab; Sirolimus; Steroids; Tacrolimus; TOR Serine-Threonine Kinases; Transplantation; Treatment Outcome | 2013 |
Effects of immunosuppressive therapy in a patient with aplastic anemia-paroxysmal nocturnal hemoglobinuria (AA-PNH) syndrome during ongoing eculizumab treatment.
Topics: Aged; Anemia, Aplastic; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Bacteremia; Blood Transfusion; Combined Modality Therapy; Complement Inactivating Agents; Cyclosporine; Escherichia coli Infections; Female; Granulocyte Colony-Stimulating Factor; Hemoglobinuria, Paroxysmal; Hemolysis; Humans; Immunosuppressive Agents; Lenograstim; Recombinant Proteins; Shock, Septic; T-Lymphocytes; Urinary Tract Infections | 2014 |
Different clinical characteristics of paroxysmal nocturnal hemoglobinuria in pediatric and adult patients.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antilymphocyte Serum; Cerebrovascular Disorders; Child; Child, Preschool; Cyclosporine; Erythrocyte Transfusion; Female; Hemoglobinuria, Paroxysmal; Hemolysis; Heparin; Humans; Infant; Infant, Newborn; L-Lactate Dehydrogenase; Male; Middle Aged; Myocardial Infarction; Neutropenia; Neutrophils; Registries; Retrospective Studies; Thromboembolism; Warfarin | 2017 |
Rituximab-based immunosuppression for autoimmune haemolytic anaemia in infants.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cyclosporine; Female; Follow-Up Studies; Hemolysis; Humans; Immunosuppressive Agents; Infant; Male; Remission Induction; Rituximab; Treatment Outcome | 2009 |
Novel cyclosporin A formulations using MPEG-hexyl-substituted polylactide micelles: a suitability study.
Topics: Animals; Cell Line; Cell Survival; Chemical Phenomena; Chick Embryo; Chorioallantoic Membrane; Cyclosporine; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Stability; Feasibility Studies; Hemolysis; Humans; Immunosuppressive Agents; Mice; Micelles; Nanotechnology; Polyesters; Polyethylene Glycols; Polymers; Toxicity Tests | 2011 |
Hyperhemolysis syndrome complicating pregnancy in homozygous δβ-thalassemia.
Topics: Adult; beta-Thalassemia; Cyclosporine; delta-Globins; Female; Hemolysis; Humans; Immunoglobulins; Pregnancy; Pregnancy Complications, Hematologic; Steroids; Syndrome; Transfusion Reaction | 2012 |
Production of oxygen free radicals and of hemolysis by cyclosporine.
Topics: Animals; Cyclosporine; Hemolysis; Malondialdehyde; Melatonin; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Superoxides | 2002 |
A peptidylprolyl cis/trans isomerase from Xenopus laevis skin: cloning, biochemical characterization and putative role in the secretion.
Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacillus megaterium; Cloning, Molecular; Cyclophilins; Cyclosporine; DNA, Complementary; Erythrocytes; Hemolysis; Humans; Molecular Sequence Data; Peptidylprolyl Isomerase; Skin; Xenopus laevis | 2003 |
Effects of epigallocatechin gallate on the hemolysis induced by cyclosporine.
Topics: Catechin; Cyclosporine; Erythrocytes; Free Radical Scavengers; Hemolysis; Humans; In Vitro Techniques | 2005 |
Characterization of DESI-FTICR mass spectrometry - from ECD to accurate mass tissue analysis.
Topics: Animals; Cyclosporine; Erythrocytes; Globins; Heme; Hemolysis; Humans; Liver; Lysophospholipids; Mice; Reproducibility of Results; Sequence Analysis, Protein; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Tandem Mass Spectrometry | 2008 |
Microangiopathy following allogeneic marrow transplantation. Association with cyclosporine and methylprednisolone for graft-versus-host disease prophylaxis.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Hemolysis; Humans; Hypertension; Immunosuppressive Agents; L-Lactate Dehydrogenase; Male; Methotrexate; Methylprednisolone; Middle Aged; Nervous System Diseases; Plasmapheresis; Platelet Count; Retrospective Studies; Syndrome; Transplantation, Homologous; Vascular Diseases | 1995 |
Reinforcement of cyclosporin A-induced red cell destruction by superoxide.
Topics: Adult; Cyclosporine; Drug Synergism; Erythrocytes; Hemolysis; Humans; Male; Superoxides; Tacrolimus | 1994 |
Prognostic factors and early resumption of cyclosporin A in renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndrome.
Topics: Adult; Antilymphocyte Serum; Arterioles; Biopsy; Cadaver; Cyclosporine; Follow-Up Studies; Forecasting; Graft Survival; Hemolysis; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Living Donors; Middle Aged; Muromonab-CD3; Prognosis; Recurrence; Retrospective Studies; Thrombocytopenia; Thrombosis; Time Factors; Transplantation, Homologous; Treatment Outcome | 1997 |
[Detection of PNH clones using flow cytometry in aplastic anemia and paroxysmal nocturnal hemoglobinuria].
Topics: Adult; Anemia, Aplastic; Antilymphocyte Serum; CD55 Antigens; CD59 Antigens; Clone Cells; Cyclosporine; Female; Flow Cytometry; Granulocytes; Hemoglobinuria; Hemoglobinuria, Paroxysmal; Hemolysis; Humans; Immunosuppressive Agents; Male; Middle Aged; T-Lymphocytes | 1999 |
Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility.
Topics: ABO Blood-Group System; Adult; Blood Group Incompatibility; Cyclosporine; Erythrocyte Transfusion; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Hemolysis; Humans; Immunosuppressive Agents; Leukemia; Leukemia, B-Cell; Leukemia, Myelomonocytic, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Monitoring, Physiologic; Prospective Studies; Transplantation Conditioning | 2001 |
Cyclosporine-associated thrombotic microangiopathy during daclizumab induction: a suggested therapeutic approach.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biomarkers; Blood Component Transfusion; Cyclosporine; Daclizumab; Drug Therapy, Combination; Female; Fibrin Fibrinogen Degradation Products; Hemolysis; Humans; Immunoglobulin G; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Living Donors; Male; Microcirculation; Middle Aged; Plasmapheresis; Polycystic Kidney Diseases; Tacrolimus; Thrombosis | 2001 |
Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate.
Topics: ABO Blood-Group System; Adult; Anemia, Aplastic; Antibodies; Blood Component Transfusion; Blood Group Incompatibility; Bone Marrow Transplantation; Coombs Test; Cyclosporine; Hemolysis; Humans; Immunosuppression Therapy; Leukemia; Methotrexate; Middle Aged; Myelodysplastic Syndromes | 1992 |